Correlation Between Renaissance IPO and Innovator IBD

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Renaissance IPO and Innovator IBD at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Renaissance IPO and Innovator IBD into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Renaissance IPO ETF and Innovator IBD 50, you can compare the effects of market volatilities on Renaissance IPO and Innovator IBD and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Renaissance IPO with a short position of Innovator IBD. Check out your portfolio center. Please also check ongoing floating volatility patterns of Renaissance IPO and Innovator IBD.

Diversification Opportunities for Renaissance IPO and Innovator IBD

0.89
  Correlation Coefficient

Very poor diversification

The 3 months correlation between Renaissance and Innovator is 0.89. Overlapping area represents the amount of risk that can be diversified away by holding Renaissance IPO ETF and Innovator IBD 50 in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Innovator IBD 50 and Renaissance IPO is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Renaissance IPO ETF are associated (or correlated) with Innovator IBD. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Innovator IBD 50 has no effect on the direction of Renaissance IPO i.e., Renaissance IPO and Innovator IBD go up and down completely randomly.

Pair Corralation between Renaissance IPO and Innovator IBD

Considering the 90-day investment horizon Renaissance IPO is expected to generate 3.41 times less return on investment than Innovator IBD. But when comparing it to its historical volatility, Renaissance IPO ETF is 1.86 times less risky than Innovator IBD. It trades about 0.15 of its potential returns per unit of risk. Innovator IBD 50 is currently generating about 0.28 of returns per unit of risk over similar time horizon. If you would invest  2,725  in Innovator IBD 50 on August 26, 2024 and sell it today you would earn a total of  371.00  from holding Innovator IBD 50 or generate 13.61% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthStrong
Accuracy100.0%
ValuesDaily Returns

Renaissance IPO ETF  vs.  Innovator IBD 50

 Performance 
       Timeline  
Renaissance IPO ETF 

Risk-Adjusted Performance

9 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Renaissance IPO ETF are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. In spite of very fragile basic indicators, Renaissance IPO may actually be approaching a critical reversion point that can send shares even higher in December 2024.
Innovator IBD 50 

Risk-Adjusted Performance

13 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Innovator IBD 50 are ranked lower than 13 (%) of all global equities and portfolios over the last 90 days. In spite of fairly uncertain basic indicators, Innovator IBD showed solid returns over the last few months and may actually be approaching a breakup point.

Renaissance IPO and Innovator IBD Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Renaissance IPO and Innovator IBD

The main advantage of trading using opposite Renaissance IPO and Innovator IBD positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Renaissance IPO position performs unexpectedly, Innovator IBD can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Innovator IBD will offset losses from the drop in Innovator IBD's long position.
The idea behind Renaissance IPO ETF and Innovator IBD 50 pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.

Other Complementary Tools

Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Money Managers
Screen money managers from public funds and ETFs managed around the world
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk